CD19 and B-cell chronic lymphocytic leukemia: A potential antileukemic NK population in CLL has been identified with a CD45RA+RO+ phenotype as well as CD19+ (suggesting trogocytosis); this population is increased in CLL patients and may suggest an active antileukemia NK response [118,119].